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Abstract
The diagnostic capability of DSMR for the detection of haemodynamically relevant, obstructive CAD is
independent of gender.
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Dobutamine stress magnetic resonance imaging for
the detection of coronary artery disease in women
R Gebker, C Jahnke, T Hucko, R Manka, J G Mirelis, A Hamdan, B Schnackenburg,
E Fleck, I Paetsch
ABSTRACT
Background Dobutamine stress magnetic resonance
(DSMR) imaging represents an excellent imaging
approach for the detection of coronary artery disease
(CAD). However, most studies have predominantly
reported the utility of DSMR in men.
Objective To evaluate the diagnostic value of DSMR in
men and women.
Methods and results High-dose dobutamine/atropine
stress magnetic resonance imaging was performed and
new or worsening wall motion abnormalities evaluated in
745 consecutive patients (204 women, 541 men).
Invasive coronary angiography was performed within
30 days and served as the reference standard ($70%
stenosis). DSMR was technically successful and had
diagnostic image quality in all patients except one woman
and three men (p¼NS). In the absence of ischaemia,
target heart rate was not reached in 9.3% of women and
8.5% of men (P¼NS) despite maximum pharmacological
infusion (1% and 2.2%, respectively, p¼NS) or owing to
limiting side effects (8.3% and 6.3%, respectively,
p¼NS). Diagnostic values (sensitivity/specificity/
accuracy) for the detection of significant coronary
stenoses were similar for men (86%/83%/85%) and
women (85%/86%/85%). There was no gender-based
difference in regional diagnostic accuracy of DSMR for all
three coronary vascular territories in patients with
single-vessel CAD (81% vs 81%, p¼NS, respectively).
Conclusion The diagnostic capability of DSMR for the
detection of haemodynamically relevant, obstructive CAD
is independent of gender.
Cardiovascular disease is the most common cause of
death amongwomen.1Although significant progress
has been made in the area of gender-specific cardio-
vascular research over the past decade, the non-
invasive diagnosis of coronary artery disease (CAD)
in women remains challenging. Exercise electrocar-
diographyhas an inferior sensitivity for the detection
of CAD in women, in part owing to a lower preva-
lence of CAD and a lower exercise capability of
women compared with men.2 Most studies on
exercise and dobutamine stress echocardiography
have reported similar diagnostic results in both
genders.3 4
Dobutamine stress magnetic resonance (DSMR)
has been established as an accurate method for
the diagnosis of CAD and has its greatest benefit
in patients who are unsuitable for stress
echocardiography.5e8 However, in most published
diagnostic studies, patients were predominantly
men.
The aim of this study was to assess the possible
influence of gender on the diagnostic value ofDSMR.
MATERIALS AND METHODS
Patient population
The study was approved by the institutional review
board at the Charité University School of Medicine
and written informed consent was given by all
patients. DSMRwas performed prospectively in 745
consecutive patients with suspected and known
CAD scheduled for clinically indicated coronary
angiography. Patients with contraindications to
either MRI (non-compatible biometallic implants or
claustrophobia) or dobutamine (acute coronary
syndrome, severe hypertension, significant aortic
stenosis, myocarditis, endocarditis, pericarditis), and
patients with arrhythmia were not considered for
study inclusion. All patients were instructed to
refrain from b blockers and antianginal medication
(nitrates, calcium antagonists) 24 h before the MR
study.
MRI
MRI was performed with the patient in the supine
position using a 1.5 T MR scanner (Philips Intera
CV, Best, The Netherlands) equipped with a Nova
gradient system (33 mT/m; 160 mT/m/ms) based
on Philips release 11. A five-element cardiac synergy
coil was used for signal reception. Cardiac
synchronisation was performed by using four
electrodes placed on the left anterior hemithorax
(vector electrocardiogram), and scans were trig-
gered on the R wave of the ECG. Cardiac standard
geometries (three short-axis views, four-, two- and
three-chamber views) were acquired at rest and
during each dobutamine stress level.
Dobutamine stress MR protocol
Dobutamine was infused via an antecubital vein
starting at a dose of 10 mg/kg/min and was
increased by 10 mg/kg/min every 3 min to a
maximum of 40 mg/kg/min. Atropine (up to 2 mg)
was given to patients not achieving 85% of age-
predicted maximum heart rate at peak dobutamine
dose. Termination criteria were as previously
published.9 The test was interrupted if severe chest
pain, significant ventricular or supraventricular
arrhythmia, hypertension (RR >240/120 mm Hg),
a systolic blood pressure decrease >40 mm Hg, or
any intolerable side effect occurred during the test.
If chest pain, arrhythmias or any intolerable side
effects occurred during testing and did not resolve
after termination of dobutamine infusion, intrave-
nous esmolol (50e100 mg) was given additionally.
MR image analysis
Left ventricular hypertrophy (LVH) was defined as
an interventricular septum thickness $12 mm in
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men and $11 mm in women.10 Isolated basal septal hyper-
trophy was accounted for by carefully double checking wall-
thickness measurements in the short-axis view and the four- and
three-chamber views. Left ventricular ejection fraction was
determined with the combined triplane model.11 All DSMR
images were evaluated using a synchronised quadscreen image
display (View Forum; Philips Medical Systems, The
Netherlands) to compare corresponding rest and increasing
stress levels. Regional wall motion was assessed in consensus by
two experienced observers who were blinded to clinical data
including gender and results of invasive coronary angiography. A
17-segment model12 was used, and segmental wall motion was
graded on a four-point scoring system (1, normal; 2, hypokinetic;
3, akinetic; 4, dyskinetic). DSMR was considered positive for
ischaemia with occurrence of new or worsening wall motion
abnormalities (WMAs) in one or more segments during any
stage of the stress test; a biphasic response was considered to
indicate ischaemia. In the absence of ischaemia, failure to attain
85% of the age-predicted maximal heart rate was identified as
a non-diagnostic result. For comparison with invasive coronary
angiography, segmental wall motion was related to the corre-
sponding coronary artery territories.12
Coronary angiography
Coronary angiography was performed in all patients within 30
days of DSMR testing. The angiograms were evaluated visually
for the presence of significant stenoses (ie, $70% luminal
diameter reduction) in the three large epicardial coronary arteries
and their major branches (ie, vessel diameter $2.0 mm) by
highly experienced invasive cardiologists; all readers were
blinded to the MR data. In patients with bypass grafts, signifi-
cant arterial or vein graft stenoses were assigned to the recipient
native coronary vessel. The angiographic results were then
classified as one-, two- and three-vessel disease or exclusion of
significant obstructive CAD.
Statistical analysis
Statistical analyses were performed using SPSS software (version
15.0; SPSS, Chicago, Illinois, USA). Unless specified, data are
presented as mean values (SD). The c2 test was used to compare
differences between proportions. The KolmogoroveSmirnov test
was used to check for normally distributed data: The Student t
test was used for analysis of continuous, normally distributed
data, otherwise the non-parametric ManneWhitney test was
applied. A p value <0.05 was considered statistically significant.
Sensitivity, specificity and accuracy were calculated according to
standard definitions. Clinical variables considered for univariate
analyses were defined according to the Framingham Risk Score
assessment as well as left ventricular ejection fraction, prior
myocardial infarction, LVH and body mass index.
RESULTS
Dobutamine stress test
Table 1 shows the reasons for termination of DSMR.
The percentage of diagnostic and non-diagnostic tests was
similar for men and women. DSMR was more often positive for
ischaemia in men (58%) than in women (41.2%, p¼0.002). In
the absence of ischaemia, 46 men (8.5%) and 19 women (9.3%,
p¼0.727) did not reach target heart rate, despite maximum
pharmacological infusion in 12 men (2.2%) and two women
(1%, p¼0.267) or as a result of limiting side effects in 34 men
(6.3%) and 17 women (8.3%, p¼0.373). Technical difficulties like
poor ECG triggering and insufficient image quality during stress
precluded interpretation of wall motion in five (1%) men and in
two (1%, p¼0.943) women. Thus, DSMR was considered diag-
nostic in 490 men (90.7%) and in 183 women (89.7%, p¼0.721).
Tables 2 and 3 show clinical and haemodynamic data of the final
population of the study, respectively.
Dobutamineeatropine induced a significant increase in heart
rate, systolic blood pressure and pulseepressure product in men
and women (p<0.001 for both genders). Peak heart rate at stress
was no different between men and women. Heart rate, systolic
blood pressure and pulseepressure product at rest were higher in
women than in men. Men had higher systolic blood pressure and
pulseepressure product at peak stress and they received higher
doses of dobutamine and atropine more frequently than women.
Table 1 Reasons for test termination
Men
(n[541)
Women
(n[204) p Value
Diagnostic tests 490 (90.7) 183 (89.7) 0.721
Positive for ischaemia 314 (58) 84 (41.2) 0.002
With heart rate $85% 269 (49.7) 78 (38.2) 0.069
With heart rate <85% 45 (8.3) 6 (2.9) 0.069
Negative (heart rate $85%) 176 (32.5) 99 (48.5) 0.002
Non-diagnostic tests 51 (9.4) 21 (10.3) 0.663
Technical reasons (insufficient ECG triggering) 2 (0.4) 1 (0.5) 0.817
Insufficient image quality 3 (0.6) 1 (0.5) 0.915
Maximum pharmacological infusion in
submaximal negative
12 (2.2) 2 (1) 0.267
Limiting side effects 34 (6.3) 17 (8.3) 0.373
Patient request 7 (1.3) 6 (2.9) 0.126
Severe chest pain 20 (3.7) 4 (2) 0.231
Severe dyspnoea 4 (0.7) 2 (1) 0.743
Severe increase in blood pressure (>240/
120 mm Hg)
3 (0.6) 1 (0.5) 0.915
Paroxysmal atrial fibrillation 13 (2.4) 3 (1.5) 0.434
Ventricular tachycardia (self limiting) 3 (0.6) 1 (0.5) 0.915
Values are number (%).
Table 2 Baseline characteristics of men and women
Characteristics
Men
(n[490)
Women
(n[183) p Value
Age (years), mean (SD) 63 (9) 64 (10) 0.183
BMI, mean (SD) 28.08 (3.8) 27.55 (4.4) 0.005
LVEF, mean (SD) 55 (9) 59 (8) <0.001
Hypertension (%) 391 (80) 131 (72) 0.023
Hyperlipidaemia (%) 377 (77) 123 (67) 0.01
Diabetes mellitus (%) 134 (27) 49 (27) 0.882
Smoking (%) 270 (55) 83 (45) 0.024
Family history (%) 171 (35) 61 (33) 0.704
Left ventricular hypertrophy 179 (37) 56 (31) 0.151
Wall thickness septum, mean (SD) 11 (1.9) 10 (1.9) <0.001
Resting WMA, mean (SD) 242 (47) 67 (44) 0.003
Prior CAD 349 (71) 100 (55) <0.001
Prior myocardial infarction 260 (53) 64 (35) <0.001
Prior PCI 305 (62) 78 (43) <0.001
Prior CABG 137 (28) 32 (18) 0.005
Vessel disease (coronary stenosis $70%)
CAD 365 (74) 99 (54) <0.001
CAD-1 215 (44) 64 (35) 0.037
CAD-2 121 (25) 27 (15) 0.006
CAD-3 29 (6) 8 (4) 0.433
CAD multivessel 150 (31) 35 (19) 0.003
Values are n (%) unless otherwise noted.
BMI, body mass index; CABG, coronary artery bypass grafting; CAD, coronary artery
disease; LVEF, left ventricular ejection fraction; PCI, percutaneous coronary intervention;
WMA, wall motion abnormality.
Heart 2010;96:616e620. doi:10.1136/hrt.2009.175521 617
Cardiac imaging and non-invasive testing
 group.bmj.com on December 2, 2010 - Published by heart.bmj.comDownloaded from 
Coronary angiography
Significant CAD ($70% stenosis) was detected in 365 men
(74%) and in 99 women (54%, p<0.001). The prevalence of
single-vessel CAD was higher in men than in women (44% vs
35%, p¼0.037).
Results of DSMR
New or worsening WMAs occurred in 314/490 (64%) men and
in 84/183 (46%) women (p<0.001). Table 4 shows the sensi-
tivity, specificity and accuracy of DSMR for the overall and
territory-based diagnosis of CAD in all patients.
Overall there were no significant differences in sensitivity,
specificity and diagnostic accuracy between men and women.
The negative predictive value of DSMR in women was signifi-
cantly higher than in men (83% vs 67%, p¼0.001). In patients
with single-vessel CAD there were no significant differences in
overall territory-based diagnostic accuracy between women and
men (81% vs 81%, p¼0.764). The sensitivity of DSMR was 91%
in patients with multivessel CAD and 82% in patients with
single-vessel CAD (p¼0.005). This trend of improved sensitivity
in patients with multivessel disease was present in both women
and men. Table 4 shows the sensitivity and specificity of DSMR
according to the number of vessels and locations of vessels.
There were no gender-related differences in diagnostic values of
DSMR in patients with LVH and patients with andwithout prior
myocardial infarction (table 4). However, specificity in patients
with prior myocardial infarction (76%) was significantly lower
than in patients without prior myocardial infarction (87%,
p¼0.05).
Variables influencing diagnostic accuracy of DSMR
Gender itself was not a univariate predictor of either false-
negative or false-positive results. The univariate causes of false-
negative studies in men were smoking (p¼0.004) and LVH
(p¼0.009), whereas in women no single predictor could be
found. The univariate causes of false-positive studies were LVH
(p¼0.009) in men and prior myocardial infarction (p¼0.033) in
women.
DISCUSSION
The principal findings of this study were that DSMR is
a feasible, safe and non-invasive method with good diagnostic
accuracy for the detection of significant CAD in both men and
women. There were no significant gender-based differences in
the overall and territory-based diagnostic accuracy of DSMR.
Regardless of gender, sensitivity of DSMR was higher in patients
with multivessel CAD than in single-vessel CAD.
Non-invasive stress testing in women
The non-invasive evaluation of myocardial ischaemia in women
has been associated with more difficulties than in men.13 Exer-
cise ECG has long been recognised as being less sensitive and less
specific in women owing to gender-related anatomical and
hormonal differences as well as a lower prevalence of CAD.2
According to current guidelines, exercise ECG is recommended as
an appropriate test in those women who can exercise to
maximum capacity.14 However, the number of women who
Table 3 Haemodynamic data
Men (n[490) Women (n[183) p Value
Heart rate at rest (bpm) 70 (13) 75 (13) <0.001
Heart rate at peak stress (bpm) 136 (13) 138 (12) 0.199
Systolic blood pressure at rest (mm Hg) 130 (22) 136 (25) 0.001
Systolic blood pressure at peak stress (mm Hg) 143 (32) 135 (29) 0.004
Pulseepressure product at rest (bpm 3 mm Hg) 9140 (2538) 10 315 (3223) <0.001
Pulseepressure product at peak stress (bpm 3 mm Hg) 19 466 (4825) 18 590 (4369) 0.032
Maximum dobutamine dose (mg/kg/min) 34.9 (7.9) 33.4 (8.20) 0.023
Atropine given, n (%) 268 (54.7) 73 (39.9) 0.001
Values are expressed as mean (SD) unless stated otherwise.
Table 4 Diagnostic performance of DSMR
Diagnostic parameters All patients Men Women
Overall diagnosis
Sensitivity 398/464 (86) 314/365 (86) 84/99 (85)
Specificity 176/209 (84) 104/125 (83) 72/84 (86)
Positive predictive value 398/431 (92) 314/335 (94) 84/96 (88)
Negative predictive value 176/242 (73) 104/155 (67) 72/87 (83)*
Accuracy 574/673 (85) 418/490 (85) 156/183 (85)
Sensitivity in single-vessel CAD 229/279 (82) 177/215 (82) 52/64 (81)
Sensitivity in multivessel CAD 169/185 (91)y 137/150 (91) 32/35 (91)
CAD1
LAD stenosis
Sensitivity 66/88 (75) 49/66 (74) 17/22 (77)
Specificity 160/191 (84) 127/149 (85) 33/42 (79)
Accuracy 226/279 (81) 176/215 (82) 50/64 (78)
LCX stenosis
Sensitivity 65/99 (66) 51/77 (66) 14/22 (64)
Specificity 158/180 (88) 121/138 (88) 37/42 (88)
Accuracy 223/279 (80) 172/215 (80) 51/64 (80)
RCA stenosis
Sensitivity 69/92 (75) 53/72 (74) 16/20 (80)
Specificity 161/187 (86) 122/143 (85) 39/44 (89)
Accuracy 230/279 (82) 175/215 (81) 55/64 (86)
All arteries
Sensitivity 200/279 (72) 153/215 (71) 47/64 (73)
Specificity 479/558 (86) 369/430 (86) 109/128 (85)
Accuracy 679/837 (81) 522/645 (81) 156/192 (81)
Patients with:
LVH
Sensitivity 139/175 (79) 111/140 (79) 28/35 (80)
Specificity 56/60 (93) 37/39 (95) 19/21 (91)
Accuracy 195/235 (83) 148/179 (83) 47/56 (84)
No prior myocardial infarction
Sensitivity 159/190 (84) 117/139 (84) 42/51 (82)
Specificity 139/159 (87)z 79/91 (87) 60/68 (88)
Accuracy 298/349 (85) 196/230 (85) 102/119 (86)
Prior myocardial infarction
Sensitivity 238/274 (87) 196/226 (87) 42/48 (88)
Specificity 38/50 (76) 26/34 (77) 12/16 (75)
Accuracy 276/324 (85) 222/260 (85) 54/64 (84)
*p¼0.001 vs men; yp¼0.005 vs CAD-1; zp¼0.05 vs prior myocardial infarction.
CAD, coronary artery disease; DSMR, dobutamine stress magnetic resonance; LAD, left
anterior descending coronary artery; LCX, left circumflex artery; LVH, left ventricular
hypertrophy; RCA, right coronary artery.
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meet this precondition is going to decline even further with the
growing incidence of obesity in a generally ageing population.
This mandates alternative, more accurate non-invasive strategies
to diagnose myocardial ischaemia. For those women unable to
attain target heart rate during physical exercise pharmacological
stress testing in combination with echocardiography or single-
photon emission computed tomography (SPECT) represent
firmly established imaging modalities for the detection of CAD.
DSMR has emerged as a relatively new non-invasive method
with high diagnostic accuracy for the recognition of CAD,
which has been demonstrated in various patient populations.5e8
Given the fact that most publications on DSMR have focused
predominantly on male populations, this study was designed to
assess the diagnostic value of DSMR for the detection of CAD in
women.
Diagnostic accuracy of DSMR
The overall results of our study concur with previous studies
assessing the clinical utility of DSMR,5e8 which have found
sensitivities of 83e89% and specificities of 80e86%. Our study
demonstrated that the diagnostic capability of DSMR for the
detection of haemodynamically relevant, obstructive CAD is
gender-independent. The higher sensitivity for the detection of
multivessel versus single-vessel CAD in our study has been
described in previous reports using dobutamine echocardiog-
raphy in a similar manner.3 This is most probably owing to the
occurrence of more extensive ischaemic WMAs, which are
readily and unequivocally identifiable with a high level of diag-
nostic confidence. The superior negative predictive value of
DSMR in women compared with men in our study was most
likely a reflection of the lower prevalence of CAD in women
(54%) versus men (74%). Our data thus indicate that the limi-
tations of DSMR are not attributed to gender-related effects but
rather to the extent and prevalence of the disease. Most studies
on dobutamine stress echocardiography examining this issue
also did not show relevant gender-related differences. According
to recently published data of a meta-analysis on dobutamine
stress echocardiography, the overall sensitivity and specificity
were 77% and 81%, respectively, for women, which did not
differ significantly from the corresponding values for men (77%
and 77%, respectively).3 The sensitivity and specificity of 85%
and 86% in women and 86% and 83% in men found in our study
compared favourably with echocardiography. Previous studies
directly comparing DSMR with dobutamine stress echocardi-
ography reported similar diagnostic values and better results for
DSMR than for echocardiography, which has been mainly
attributed to the consistently high endocardial border definition
of cine MRI.6 Although technical advances like harmonic
imaging have led to major improvements in echocardiographic
image quality, the performance of the examination largely
depends on user experience, and a relevant number of patients
still remain unsuitable candidates owing to poor endocardial
border visualisation of the left ventricle (eg, post-thoracotomy,
chronic obstructive pulmonary disease, obesity).15 16
Furthermore, DSMR yielded a high number of diagnostic
examinations in our study as 90.7% of men and 89.7% of women
were either positive for ischaemia or negative after reaching target
heart rate. Insufficient image quality was the cause of non-diag-
nostic examinations in 0.6% of patients only (three men, one
woman), reflecting the overall excellent ability of cardiac MRI to
depict all left ventricular segments in a user-independentway.The
occurrence of dose-limiting side effects and submaximum heart
rate responses accounted for the majority of non-diagnostic
examinations and were similar in men and women. These
numbers are comparable with other imaging techniques using
dobutamine as a pharmacological stress agent.3 17
The chronotropic and haemodynamic response in our study
differed by gender. Men needed higher doses of dobutamine and
received atropine more frequently than women to achieve target
heart rate. Systolic blood pressure and pulseepressure product at
peak stress were higher in men than in women. These findings
confirm previous studies on gender differences using dobutamine
stress echocardiography.18 In contrast to our results, Aquilante et
al reported that women had a slightly higher blood pressure
response during dobutamine infusion than men. Their findings
may have been confounded by including a larger number of
African-American patients, who generally demonstrated a higher
blood pressure throughout the stress examination.19
The localisation of left ventricular segments with stress-
inducible WMAs showed good correlation with the presence of
haemodynamically relevant stenoses in individual coronary
arteries. Compared with stress nuclear scintigraphy, which is
known to have attenuation artefacts overlying the inferior wall
in women and overweight patients, DSMR performed favour-
ably since specificity for the detection of CAD in segments
supplied by the right coronary artery was equally high as in
other territories and body mass index was not associated with
more false-positive results.20 21
In both genders prior myocardial infarction was associated
with reduced specificity, a finding, which has also been reported
by authors using dobutamine stress echocardiography.22 23 The
development of tethering effects during dobutamine stress in
segments adjacent to areas of infarcted myocardium might serve
as an explanation for more false-positive results in this patient
population. In men LVH and smoking were independent
predictors for false-negative results in our study. The reasons for
this remain incompletely understood. Changes in wall thickness
and mass may alter systolic wall stress of the left ventricle and
might influence the ischaemic threshold. In patients with LVH,
left ventricular obliteration during dobutamine stress and dia-
stolic dysfunction with increased myocardial stiffness are
known phenomena which can interfere with the identification
of WMAs.24 Although LVH was evenly distributed among men
and women, men had significantly greater absolute values of left
ventricular wall thickness, which may have resulted in more
false-negative results.
Study limitations
Most of the study patients had a previous coronary intervention
or prior myocardial infarction and, thus, the prevalence of CAD
was high. Therefore, these patients represent a high-risk cohort
that is usually referred to a tertiary centre rather than the overall
population subjected to non-invasive testing. A similar study in
a large group of patients with suspected CAD only, particularly
in those with an intermediate probability of CAD may be of
value. By using the standard American Heart Association 17-
segment model to assign myocardial segments to each coronary
artery, we did not correct for the high variability in coronary
blood supply to individual myocardial segments.12
Competing interests None.
Ethics approval Ethics committee approval from the institutional review board at the
Charite´ University School of Medicine, Berlin, Germany.
Provenance and Peer review Not commissioned; externally peer reviewed.
REFERENCES
1. Rosamond W, Flegal K, Friday G, et al. Heart disease and stroke statisticsd2007
update: a report from the American Heart Association Statistics Committee and
Stroke Statistics Subcommittee. Circulation 2007;115:e69e171.
Heart 2010;96:616e620. doi:10.1136/hrt.2009.175521 619
Cardiac imaging and non-invasive testing
 group.bmj.com on December 2, 2010 - Published by heart.bmj.comDownloaded from 
2. Curzen N, Patel D, Clarke D, et al. Women with chest pain: is exercise testing
worthwhile? Heart 1996;76:156e60.
3. Geleijnse ML, Krenning BJ, Soliman OI, et al. Dobutamine stress echocardiography
for the detection of coronary artery disease in women. Am J Cardiol 2007;99:714e7.
4. Marwick TH, Anderson T, Williams MJ, et al. Exercise echocardiography is an
accurate and cost-efficient technique for detection of coronary artery disease in
women. J Am Coll Cardiol 1995;26:335e41.
5. Hundley WG, Hamilton CA, Thomas MS, et al. Utility of fast cine magnetic
resonance imaging and display for the detection of myocardial ischemia in patients
not well suited for second harmonic stress echocardiography. Circulation
1999;100:1697e702.
6. Nagel E, Lehmkuhl HB, Bocksch W, et al. Noninvasive diagnosis of ischemia-induced
wall motion abnormalities with the use of high-dose dobutamine stress MRI:
comparison with dobutamine stress echocardiography. Circulation 1999;99:763e70.
7. Paetsch I, Jahnke C, Wahl A, et al. Comparison of dobutamine stress magnetic
resonance, adenosine stress magnetic resonance, and adenosine stress magnetic
resonance perfusion. Circulation 2004;110:835e42.
8. Wahl A, Paetsch I, Roethemeyer S, et al. High-dose dobutamine-atropine stress
cardiovascular MR imaging after coronary revascularization in patients with wall
motion abnormalities at rest. Radiology 2004;233:210e6.
9. Paetsch I, Jahnke C, Fleck E, et al. Current clinical applications of stress wall motion
analysis with cardiac magnetic resonance imaging. Eur J Echocardiogr
2005;6:317e26.
10. Salton CJ, Chuang ML, O’Donnell CJ, et al. Gender differences and normal left
ventricular anatomy in an adult population free of hypertension. A cardiovascular
magnetic resonance study of the Framingham Heart Study Offspring cohort. J Am
Coll Cardiol 2002;39:1055e60.
11. Thiele H, Paetsch I, Schnackenburg B, et al. Improved accuracy of quantitative
assessment of left ventricular volume and ejection fraction by geometric models with
steady-state free precession. J Cardiovasc Magn Reson 2002;4:327e39.
12. Cerqueira MD, Weissman NJ, Dilsizian V, et al. Standardized myocardial
segmentation and nomenclature for tomographic imaging of the heart: a statement
for healthcare professionals from the Cardiac Imaging Committee of the Council on
Clinical Cardiology of the American Heart Association. Circulation 2002;105:539e42.
13. Sketch MH, Mohiuddin SM, Lynch JD, et al. Significant sex differences in the
correlation of electrocardiographic exercise testing and coronary arteriograms. Am J
Cardiol 1975;36:169e73.
14. Mieres JH, Shaw LJ, Arai A, et al. Role of noninvasive testing in the clinical
evaluation of women with suspected coronary artery disease: consensus statement
from the Cardiac Imaging Committee, Council on Clinical Cardiology, and the
Cardiovascular Imaging and Intervention Committee, Council on Cardiovascular
Radiology and Intervention, American Heart Association. Circulation
2005;111:682e96.
15. Hoffmann R, Borges AC, Kasprzak JD, et al. Analysis of myocardial perfusion
or myocardial function for detection of regional myocardial abnormalities. An
echocardiographic multicenter comparison study using myocardial
contrast echocardiography and 2D echocardiography. Eur J Echocardiogr
2007;8:438e48.
16. Hoffmann R, Lethen H, Marwick T, et al. Analysis of interinstitutional observer
agreement in interpretation of dobutamine stress echocardiograms. J Am Coll Cardiol
1996;27:330e6.
17. Elhendy A, Bax JJ, Poldermans D. Dobutamine stress myocardial perfusion imaging
in coronary artery disease. J Nucl Med 2002;43:1634e46.
18. Tsutsui JM, Falcao SN, Dourado PM, et al. Gender differences in chronotropic and
hemodynamic responses during dobutamine-atropine stress echocardiography.
Echocardiography 2007;24:843e50.
19. Aquilante CL, Humma LM, Yarandi HN, et al. Influence of gender and race on
hemodynamic response to dobutamine during dobutamine stress echocardiography.
Am J Cardiol 2004;94:535e8.
20. Freedman N, Schechter D, Klein M, et al. SPECT attenuation artifacts in normal and
overweight persons: insights from a retrospective comparison of Rb-82 positron
emission tomography and TI-201 SPECT myocardial perfusion imaging. Clin Nucl Med
2000;25:1019e23.
21. Kwok Y, Kim C, Grady D, et al. Meta-analysis of exercise testing to detect coronary
artery disease in women. Am J Cardiol 1999;83:660e6.
22. Dionisopoulos PN, Collins JD, Smart SC, et al. The value of dobutamine stress
echocardiography for the detection of coronary artery disease in women. J Am Soc
Echocardiogr 1997;10:811e7.
23. Marcovitz PA, Armstrong WF. Accuracy of dobutamine stress echocardiography in
detecting coronary artery disease. Am J Cardiol 1992;69:1269e73.
24. Smart SC, Knickelbine T, Malik F, et al. Dobutamine-atropine stress
echocardiography for the detection of coronary artery disease in patients with left
ventricular hypertrophy. Importance of chamber size and systolic wall stress.
Circulation 2000;101:258e63.
620 Heart 2010;96:616e620. doi:10.1136/hrt.2009.175521
Cardiac imaging and non-invasive testing
 group.bmj.com on December 2, 2010 - Published by heart.bmj.comDownloaded from 
